NeuroBo - Netong Asset Bawat Isang Bahagi NRBO

NeuroBo Pharmaceuticals (NRBO) - korporatibong logo

Ang NeuroBo Pharmaceuticals (NRBO) ay dumidepende sa mga external contractor para sa mga kapasidad ng produksyon nito upang bumuo ng mga gamot para sa mga metabolic disorder. Ang book value per share ng kumpanya ay nagpapakita ng equity dynamics, kung saan ang 1.49 ang nagsisilbing kasalukuyang metric. Ang estratehiya ay nakabase sa proteksyon ng atay habang nilalabanan ang obesity, habang nakatuon naman ang pamunuan sa mga FDA test, isinasaalang-alang ang impluwensya ng isang malaking Korean owner.

Stockholders Equity Bawat Bahagi NeuroBo Pharmaceuticals Inc (NRBO): para sa panahong 04.07.2022 - 07.12.2024

neurobopharma.com - mga analytical breakdown at pangunahing sukatan (NRBO)

- presyo at pagtataya ng pinagkasunduang presyo:
Presyo ng Stock NeuroBo|NRBO - Tsart ng Target na Presyo
- datos sa market capitalization:
Halaga sa Merkado NeuroBo Pharmaceuticals, Inc.|NRBO - Kabuuang Halaga ng Negosyo
- datos sa book capitalization:
Netong Asset Bawat Isang Bahagi NeuroBo Pharmaceuticals|NRBO - Accounting Capitalization|Ratio ng Market Capitalization sa Book Value neurobopharma.com|NRBO - Mga Asset ng Kumpanya
- datos sa utang at liquidity:
Ratio ng Kabuuang Utang sa Stockholders Equity NeuroBo Pharmaceuticals|NRBO - Pangmatagalang utang sa kapital|Panandaliang utang sa equity NeuroBo Pharmaceuticals, Inc.|NRBO - Mga pinagsamang obligasyon sa utang|Ratio ng utang sa book capitalization NeuroBo Pharmaceuticals, Inc.
Fundamental valuation ng kumpanya:NeuroBo, NRBO
Mga produktong ginagawa ng NeuroBo Pharmaceuticals, Inc.

Ang isang investment audit ng issuer ay nangangailangan ng pagsusuri ng equity na hinati sa bilang ng mga shares outstanding, na nagbibigay-daan para sa pagtukoy ng tunay na halaga ng stake sa negosyo nang hindi kasama ang market speculation. Para sa NeuroBo Pharmaceuticals (NRBO), na lumalawak sa pamamagitan ng mga R&D partnership kasama ang parent holding company nito nang walang external na M&A, ang historical book value per share ay nagsisilbing indicator ng financial stability at ng efficiency ng internal resource accumulation.

Pagsusuri ng mga kakumpitensya ng NeuroBo Pharmaceuticals

BIIB - Book Value Bawat Bahagi|NBIX: Netong Asset Bawat Isang Bahagi|Netong Asset Bawat Isang Bahagi RGC|AXSM (axsome.com) - Net Asset Value Bawat Bahagi|Netong Asset Bawat Isang Bahagi ACADIA Pharmaceuticals Inc. (ACAD)|Stockholders Equity Bawat Bahagi Xenon Pharmaceuticals Inc.|Viking Pharma - Book Value Bawat Bahagi|Net Asset Value Bawat Bahagi Supernus Corp SUPN|Accounting Book Value Bawat Bahagi CPRX (Catalyst Pharmaceuticals)|denalitherapeutics.com - Book Value Bawat Bahagi|Netong Asset Bawat Isang Bahagi Harmony Biosciences Holdings, Inc. (HRMY)|BHVN: Accounting Value ng Bahagi|Netong Asset Bawat Isang Bahagi AMLX|TRVI (Trevi Corp) - Net Asset Value Bawat Bahagi|Netong Asset Bawat Isang Bahagi Praxis Precision Medicines (PRAX)|Stockholders Equity Bawat Bahagi anavex.com|CeriBell - Book Value Bawat Bahagi|Net Asset Value Bawat Bahagi Prothena Corporation PRTA|Accounting Book Value Bawat Bahagi ALEC (Alector)|Annexon Biosciences Inc. - Book Value Bawat Bahagi|Netong Asset Bawat Isang Bahagi Omeros Corp. (OMER)|NGNE: Accounting Value ng Bahagi|Netong Asset Bawat Isang Bahagi ACIU|Voyager Therapeutics Inc (VYGR) - Net Asset Value Bawat Bahagi|Book Value Bawat Bahagi Neumora Therapeutics Inc|Netong Asset Bawat Isang Bahagi SCLX|Tevogen Bio Holdings - Netong Asset Bawat Isang Bahagi|Net Asset Value Bawat Bahagi alphacognition.com ACOG|Accounting Book Value Bawat Bahagi Cognition Therapeutics|Inhibikase Therapeutics Inc - Accounting Value ng Bahagi|Netong Asset Bawat Isang Bahagi Cassava|ASRT - Book Value ng Bahagi|Book Value Bawat Bahagi coyatherapeutics.com COYA|Vistagen (VTGN) - Accounting Value ng Bahagi|OVID (Ovid Therapeutics Inc) - Book Value Bawat Bahagi|Book Value Bawat Bahagi ABOS|CervoMed Inc (CRVO) - Netong Asset Bawat Isang Bahagi|Accounting Value ng Bahagi ATHE (alteritytherapeutics.com)|Clene - Netong Asset Bawat Isang Bahagi|Accounting Book Value Bawat Bahagi PepGen Inc PEPG|Jupiter Neurosciences Inc - Book Value Bawat Bahagi|RLMD - Book Value Bawat Bahagi|ANVS (Annovis Bio Corp) - Book Value Bawat Bahagi|Grace Therapeutics (GRCE) - Accounting Book Value Bawat Bahagi|Book Value Bawat Bahagi AIFF (Firefly Neuroscience, Inc)|Net Asset Value Bawat Bahagi ANEW Medical, Inc. (KLTO)|Accounting Book Value Bawat Bahagi NRSN|Book Value Bawat Bahagi Reviva Pharmaceuticals Holdings Inc. RVPH|Accounting Book Value Bawat Bahagi MetaVia (MTVA)|Book Price ng Bahagi NeurAxis Inc NRXS|Book Value Bawat Bahagi HSDT (Helius Medical Technologies Inc.)|PASG - Net Assets Bawat Bahagi|NEUP (bionomics.com.au) - Book Value Bawat Bahagi|Minerva Neurosciences Inc (NERV) - Accounting Book Value Bawat Bahagi|ATHA (Athira) - Book Value Bawat Bahagi|Book Value Bawat Bahagi ADXN|Netong Asset Bawat Isang Bahagi Alzamend Neuro, Inc. (ALZN)|Netong Asset Bawat Isang Bahagi CYCN (cyclerion.com)|Netong Asset Bawat Isang Bahagi PTIX|Pasithea Therapeutics Corp - Net Assets Bawat Bahagi|Cortigent Medical (CRGT) - Netong Asset Bawat Isang Bahagi|ATXI: Stockholders Equity Bawat Bahagi|Netong Asset Bawat Isang Bahagi Brainstorm Cell BCLI|caratherapeutics.com (CARA) - Accounting Value ng Bahagi|Book Value Bawat Bahagi Chromocell Therapeutics Corp.|Netong Asset Bawat Isang Bahagi ELYM|Intra-Cellular Therapies - Netong Asset Bawat Isang Bahagi|Net Asset Value Bawat Bahagi LBPH (Longboard)|MRNS - Netong Asset Bawat Isang Bahagi|Stockholders Equity Bawat Bahagi nkgenbiotech.com NKGN|SAGE (Sage Therapeutics) - Book Value Bawat Bahagi|Synaptogenix Inc. (SNPX) - Net Asset Value Bawat Bahagi|TRVN: Accounting Book Value Bawat Bahagi|VIGL (Vigil Neuroscience, Inc.) - Book Value Bawat Bahagi|WENA - Netong Asset Bawat Isang Bahagi|Accounting Value ng Bahagi CERE